Johnson & Johnson (NYSE:JNJ) – Experts See The Stock A Different Way Today

In the last trading session, 9.51 million shares of the Johnson & Johnson (NYSE:JNJ) were traded, and its beta was 0.54. Most recently the company’s share price was $149.12, and it changed around $1.21 or 0.82% from the last close, which brings the market valuation of the company to $359.35B. JNJ currently trades at a discount to its 52-week high of $175.97, offering almost -18.01% off that amount. The share price’s 52-week low was $143.13, which indicates that the current value has risen by an impressive 4.02% since then. We note from Johnson & Johnson’s average daily trading volume that its 3-month average coming to 7.49 million.

Johnson & Johnson stock received a consensus recommendation rating of Buy, based on a mean score of 2.22. If we narrow it down even further, the data shows that 2 out of 23 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 8 recommended JNJ as a Hold, whereas 8 deemed it a Buy, and 1 rated it as Underweight. Johnson & Johnson is expected to report earnings per share of $Johnson & Johnson for the current quarter.

Johnson & Johnson (NYSE:JNJ) trade information

Instantly JNJ has showed a green trend with a performance of 0.82% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -4.86% year-to-date, but still up 1.04% over the last five days. On the other hand, Johnson & Johnson (NYSE:JNJ) is -4.26% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $177.57, which translates to bulls needing to increase their stock price by 16.02% from its current value. Analyst projections state that JNJ is forecast to be at a low of $155 and a high of $205.

Johnson & Johnson (JNJ) estimates and forecasts

Johnson & Johnson share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -2.10 percent over the past six months and at a 7.36% annual growth rate that is well above the industry average of 3.70%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -0.27%. Johnson & Johnson earnings are expected to increase by 7.41% in 2024, but the outlook is positive 5.23% per year for the next five years.

JNJ Dividends

Johnson & Johnson’s next quarterly earnings report is expected to be released in May. The annual dividend yield of the stock is 3.19 percent and its annual dividend per share was 4.76. It is important to note, however, that the 3.19% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.